SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041347
Filing Date
2023-08-10
Accepted
2023-08-10 16:16:55
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20230630.htm   iXBRL 10-Q 3521811
2 EX-3.1 vtyx-ex3_1.htm EX-3.1 59337
3 EX-31.1 vtyx-ex31_1.htm EX-31.1 22818
4 EX-31.2 vtyx-ex31_2.htm EX-31.2 22839
5 EX-32.1 vtyx-ex32_1.htm EX-32.1 13587
6 EX-32.2 vtyx-ex32_2.htm EX-32.2 13608
  Complete submission text file 0000950170-23-041347.txt   11745968

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20230630_pre.xml EX-101.PRE 397249
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20230630_lab.xml EX-101.LAB 501118
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtyx-20230630_def.xml EX-101.DEF 261185
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20230630.xsd EX-101.SCH 58706
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtyx-20230630_cal.xml EX-101.CAL 50309
66 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20230630_htm.xml XML 2366104
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 231159721
SIC: 2834 Pharmaceutical Preparations